Dhaliwal Harpreet S. (CIK 1886794) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-11). Recent activity: Sell PCVX (604 shares), Buy PCVX (53,409 shares), Sell PCVX (292 shares), Sell PCVX (465 shares), Sell PCVX (9,743 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-11 | Vaxcyte, Inc. (PCVX) | Chief Technical Ops Officer | Sell | 604 | $35,829 |
| 2026-03-02 | Vaxcyte, Inc. (PCVX) | Chief Technical Ops Officer | Buy | 53,409 | $0 |
| 2026-03-02 | Vaxcyte, Inc. (PCVX) | Chief Technical Ops Officer | Sell | 292 | $18,098 |
| 2026-03-02 | Vaxcyte, Inc. (PCVX) | Chief Technical Ops Officer | Sell | 465 | $28,821 |
| 2026-01-02 | Vaxcyte, Inc. (PCVX) | Chief Technical Ops Officer | Sell | 9,743 | $454,901 |
| 2025-09-10 | Vaxcyte, Inc. (PCVX) | Chief Technical Ops Officer | Sell | 1,204 | $39,022 |
| 2025-09-04 | Vaxcyte, Inc. (PCVX) | Chief Technical Ops Officer | Sell | 291 | $9,184 |
| 2025-09-04 | Vaxcyte, Inc. (PCVX) | Chief Technical Ops Officer | Sell | 783 | $24,711 |
| 2025-09-04 | Vaxcyte, Inc. (PCVX) | Chief Technical Ops Officer | Sell | 464 | $14,644 |
Source: SEC Form 4 filings · as of 2026-03-11